Showing results (521-530 of 9,400) with videos related to

Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|November 9, 2022
How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT)Binglan Li, Katrin Sangkuhl, Karl Keat, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Disposition kinetics and dynamics of nicainoprol, a new antiarrhythmic agent, in humansT Ishizaki, Y Horai, K Kubota, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Total and free ketoprofen in serum and synovial fluid after intramuscular injectionP Netter, B Bannwarth, F Lapicque, et al.
Clinical Pharmacology and Therapeutics|March 1, 1992
The method of relative drug accumulation: a simple method for illustrating the effects of different drug dosing regimens and variability in drug elimination on time courses of drug concentrationsT D Bjornsson
Clinical Pharmacology and Therapeutics|August 9, 2005
Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patientsMasahide Fukudo, Ikuko Yano, Satohiro Masuda, et al.
Clinical Pharmacology and Therapeutics|August 9, 2005
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humansMartin Brunner, Oliver Langer, Raute Sunder-Plassmann, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivoPing He, Michael H Court, David J Greenblatt, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
Human response to alpha2-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: Biphasic influence of dose, age, gender, and receptor genotypeDanuta King, Jason P Etzel, Shagun Chopra, et al.
Clinical Pharmacology and Therapeutics|July 4, 2006
VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulationTom Schalekamp, Bjorn P Brassé, Janine F M Roijers, et al.
Clinical Pharmacology and Therapeutics|August 8, 2006
Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndromeRachele Berria, Amalia Gastaldelli, Scott Lucidi, et al.
Pageof 940